Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
Identifieur interne : 002881 ( PubMed/Curation ); précédent : 002880; suivant : 002882Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
Auteurs : Gerold Hoever [Allemagne] ; Lidia Baltina ; Martin Michaelis ; Rimma Kondratenko ; Lia Baltina ; Genrich A. Tolstikov ; Hans W. Doerr ; Jindrich CinatlSource :
- Journal of medicinal chemistry [ 0022-2623 ] ; 2005.
Descripteurs français
- KwdFr :
- Acide glycyrrhizique (), Acide glycyrrhizique (analogues et dérivés), Acide glycyrrhizique (pharmacologie), Acide glycyrrhizique (synthèse chimique), Animaux, Antiviraux (), Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Cellules Vero, Relation structure-activité, Réplication virale (), Virus du SRAS (), Virus du SRAS (isolement et purification).
- MESH :
- analogues et dérivés : Acide glycyrrhizique.
- isolement et purification : Virus du SRAS.
- pharmacologie : Acide glycyrrhizique, Antiviraux.
- synthèse chimique : Acide glycyrrhizique, Antiviraux.
- Acide glycyrrhizique, Animaux, Antiviraux, Cellules Vero, Relation structure-activité, Réplication virale, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Chlorocebus aethiops, Glycyrrhizic Acid (analogs & derivatives), Glycyrrhizic Acid (chemical synthesis), Glycyrrhizic Acid (chemistry), Glycyrrhizic Acid (pharmacology), SARS Virus (drug effects), SARS Virus (isolation & purification), Structure-Activity Relationship, Vero Cells, Virus Replication (drug effects).
- MESH :
- chemical , analogs & derivatives : Glycyrrhizic Acid.
- chemical , chemical synthesis : Antiviral Agents, Glycyrrhizic Acid.
- chemical , chemistry : Antiviral Agents, Glycyrrhizic Acid.
- chemical , pharmacology : Antiviral Agents, Glycyrrhizic Acid.
- drug effects : SARS Virus, Virus Replication.
- isolation & purification : SARS Virus.
- Animals, Chlorocebus aethiops, Structure-Activity Relationship, Vero Cells.
Abstract
Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-beta-d-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.
DOI: 10.1021/jm0493008
PubMed: 15715493
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002881
Links to Exploration step
pubmed:15715493Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.</title>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Baltina, Lidia" sort="Baltina, Lidia" uniqKey="Baltina L" first="Lidia" last="Baltina">Lidia Baltina</name>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Kondratenko, Rimma" sort="Kondratenko, Rimma" uniqKey="Kondratenko R" first="Rimma" last="Kondratenko">Rimma Kondratenko</name>
</author>
<author><name sortKey="Baltina, Lia" sort="Baltina, Lia" uniqKey="Baltina L" first="Lia" last="Baltina">Lia Baltina</name>
</author>
<author><name sortKey="Tolstikov, Genrich A" sort="Tolstikov, Genrich A" uniqKey="Tolstikov G" first="Genrich A" last="Tolstikov">Genrich A. Tolstikov</name>
</author>
<author><name sortKey="Doerr, Hans W" sort="Doerr, Hans W" uniqKey="Doerr H" first="Hans W" last="Doerr">Hans W. Doerr</name>
</author>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15715493</idno>
<idno type="pmid">15715493</idno>
<idno type="doi">10.1021/jm0493008</idno>
<idno type="wicri:Area/PubMed/Corpus">002881</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002881</idno>
<idno type="wicri:Area/PubMed/Curation">002881</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002881</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.</title>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Baltina, Lidia" sort="Baltina, Lidia" uniqKey="Baltina L" first="Lidia" last="Baltina">Lidia Baltina</name>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Kondratenko, Rimma" sort="Kondratenko, Rimma" uniqKey="Kondratenko R" first="Rimma" last="Kondratenko">Rimma Kondratenko</name>
</author>
<author><name sortKey="Baltina, Lia" sort="Baltina, Lia" uniqKey="Baltina L" first="Lia" last="Baltina">Lia Baltina</name>
</author>
<author><name sortKey="Tolstikov, Genrich A" sort="Tolstikov, Genrich A" uniqKey="Tolstikov G" first="Genrich A" last="Tolstikov">Genrich A. Tolstikov</name>
</author>
<author><name sortKey="Doerr, Hans W" sort="Doerr, Hans W" uniqKey="Doerr H" first="Hans W" last="Doerr">Hans W. Doerr</name>
</author>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
</analytic>
<series><title level="j">Journal of medicinal chemistry</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Chlorocebus aethiops</term>
<term>Glycyrrhizic Acid (analogs & derivatives)</term>
<term>Glycyrrhizic Acid (chemical synthesis)</term>
<term>Glycyrrhizic Acid (chemistry)</term>
<term>Glycyrrhizic Acid (pharmacology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Structure-Activity Relationship</term>
<term>Vero Cells</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide glycyrrhizique ()</term>
<term>Acide glycyrrhizique (analogues et dérivés)</term>
<term>Acide glycyrrhizique (pharmacologie)</term>
<term>Acide glycyrrhizique (synthèse chimique)</term>
<term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Cellules Vero</term>
<term>Relation structure-activité</term>
<term>Réplication virale ()</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Acide glycyrrhizique</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Structure-Activity Relationship</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Animaux</term>
<term>Antiviraux</term>
<term>Cellules Vero</term>
<term>Relation structure-activité</term>
<term>Réplication virale</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-beta-d-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15715493</PMID>
<DateCompleted><Year>2005</Year>
<Month>04</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2623</ISSN>
<JournalIssue CitedMedium="Print"><Volume>48</Volume>
<Issue>4</Issue>
<PubDate><Year>2005</Year>
<Month>Feb</Month>
<Day>24</Day>
</PubDate>
</JournalIssue>
<Title>Journal of medicinal chemistry</Title>
<ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>1256-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-beta-d-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoever</LastName>
<ForeName>Gerold</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baltina</LastName>
<ForeName>Lidia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Michaelis</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kondratenko</LastName>
<ForeName>Rimma</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Baltina</LastName>
<ForeName>Lia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tolstikov</LastName>
<ForeName>Genrich A</ForeName>
<Initials>GA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Doerr</LastName>
<ForeName>Hans W</ForeName>
<Initials>HW</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cinatl</LastName>
<ForeName>Jindrich</ForeName>
<Initials>J</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Med Chem</MedlineTA>
<NlmUniqueID>9716531</NlmUniqueID>
<ISSNLinking>0022-2623</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6FO62043WK</RegistryNumber>
<NameOfSubstance UI="D019695">Glycyrrhizic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019695" MajorTopicYN="N">Glycyrrhizic Acid</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15715493</ArticleId>
<ArticleId IdType="doi">10.1021/jm0493008</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002881 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002881 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:15715493 |texte= Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15715493" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |